Er-Kang Pharmaceutical's subsidiary gets approvals for its APIs

Hunan Er-Kang Pharmaceutical Co., Ltd. (Er-Kang Pharmaceutical) announced on 1 March that its wholly-owned subsidiary, Hunan Xiangyikang Pharmaceutical Co., Ltd.'s nitrofurantoin APIs, nicotinamide APIs, cetirizine hydrochloride APIs and tetracycline...

Vitamins China E-News 202103

www.cnchemicals.com